About InterAx Biotech
InterAx Biotech is a company based in Villigen (Switzerland) founded in 2016.. InterAx Biotech has raised $3.19 million across 7 funding rounds from investors including European Union, Verve Ventures and Investiere. InterAx Biotech offers products and services including Drug Discovery Platform and Lead Molecule Generation. InterAx Biotech operates in a competitive market with competitors including Slingshot Bioscience, Magnitude Biosciences, StemoniX, Signal Pharmaceuticals and Sequence Bio, among others.
- Headquarter Villigen, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Interax Biotech Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.19 M (USD)
in 7 rounds
-
Latest Funding Round
$343.2 K (USD), Grant
Feb 01, 2020
-
Investors
European Union
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InterAx Biotech
InterAx Biotech offers a comprehensive portfolio of products and services, including Drug Discovery Platform and Lead Molecule Generation. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI and modeling tool for creating high-efficacy drug leads
Process using experimental methods for safe drug candidates
Unlock access to complete
Unlock access to complete
Funding Insights of InterAx Biotech
InterAx Biotech has successfully raised a total of $3.19M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $343.2 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $343,204
-
First Round
First Round
(17 Feb 2016)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Grant - InterAx Biotech | Valuation |
investors |
|
| Oct, 2019 | Amount | Grant - InterAx Biotech | Valuation |
investors |
|
| Jan, 2019 | Amount | Series A - InterAx Biotech | Valuation | Verve Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InterAx Biotech
InterAx Biotech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Verve Ventures and Investiere. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on science and tech-driven startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InterAx Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InterAx Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Interax Biotech Comparisons
Competitors of InterAx Biotech
InterAx Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, Magnitude Biosciences, StemoniX, Signal Pharmaceuticals and Sequence Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| domain | founded_year | HQ Location |
Cell-free in vitro assays are supplied to drug discovery firms.
|
|
| domain | founded_year | HQ Location |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs regulating disease-associated genes are developed.
|
|
| domain | founded_year | HQ Location |
Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Interax Biotech
Frequently Asked Questions about InterAx Biotech
When was InterAx Biotech founded?
InterAx Biotech was founded in 2016.
Where is InterAx Biotech located?
InterAx Biotech is headquartered in Villigen, Switzerland. It is registered at Villigen, Aargau, Switzerland.
Is InterAx Biotech a funded company?
InterAx Biotech is a funded company, having raised a total of $3.19M across 7 funding rounds to date. The company's 1st funding round was a Series A of $3.05M, raised on Feb 17, 2016.
What does InterAx Biotech do?
InterAx Biotech is a spin-off from ETH Zurich that uses mutated arrestins as novel biosensors and has a computational platform for analysis. They have a combination of proprietary arrestin-based biosensors and computational methods which allow for quantitative comparison of drug-induced GPCR signalling pathways. This helps the identification of not just the GPCR reaction with the drug, but also if the reaction is beneficial or adverse. The company develops and sells drug screening packages which help in selecting drug candidates, quantifying cellular responses and in predicting drug action. The company offers two main product lines of Arrestin mutants (with biosensor applications) for in-vitro assays and cellular assays. The company also offers image analysis services mainly for fluorescence microscopy images which help in detecting, delineating and quantifying subcellular structures. The company is supported by the Paul Scherer Institute and a finalist of the Swiss Innovation Challenge.
Who are the top competitors of InterAx Biotech?
InterAx Biotech's top competitors include Magnitude Biosciences, Slingshot Bioscience and StemoniX.
What products or services does InterAx Biotech offer?
InterAx Biotech offers Drug Discovery Platform and Lead Molecule Generation.
Who are InterAx Biotech's investors?
InterAx Biotech has 6 investors. Key investors include European Union, Verve Ventures, Investiere, Falcon III Ventures, and EIC Fund.